NOV 14, 2018 6:00 AM PST

Improving Sepsis Management with Same-Day Results from the Lab

Speaker
  • President and CEO, T2 Biosystems
    Biography
      At the helm of T2 Biosystems, Mr. McDonough and his team took a new technology concept from MIT and MGH and grew it into a publicly-traded company that has the first and only FDA-cleared diagnostic products to directly detect sepsis-causing pathogens in blood. T2Direct Diagnostics™ are improving patient care in over 160 hospitals worldwide - helping patients with potentially life-threatening illness receive targeted treatment as much as eight times faster.

    Abstract

    Sepsis is the Achilles’ heel of health care. Despite being relatively unknown to the public, it is a top killer in hospitals and the cost burden is crushing to our healthcare system. More and more, sepsis is keeping hospital CFO’s up at night and is the focus of widespread hospital initiatives. And labs play a critical role in providing a solution that provides return on investment for hospitals and improves patient care.

    Hospitals’ top defense against sepsis today is empiric therapy, a probability based approach with broad-spectrum antibiotic care in the absence of species-specific information about the cause of a patient’s infection (if they have an infection at all). Despite the successes of empiric therapy, it is still severely limited by lack of actionable diagnostic information, with studies demonstrating that up to 40% of bloodstream infections receive incorrect treatment.

    In this talk, entrepreneur and CEO John McDonough will share how lab implementation of rapid diagnostics can significantly improve empiric therapy, reduce costs, and potentially save lives. New tests now available in over 160 hospitals worldwide allow for more targeted empiric therapy, improving patient outcomes and driving down hospital costs through reduced length of stay and pharmacy costs. Mr. McDonough will present on the breakthrough T2Bacteria and T2Candida Panels, the first FDA-cleared tests to directly provide species-specific results for sepsis-causing pathogens in 3 to 5 hours, without the wait for blood culture. 

     
    Learning Objectives: 

    1. Review the efficacy of empiric therapy for patients at risk of sepsis and blood stream infections
    2. Describe the limitations of current sepsis management
    3. Review T2MR technology for rapid identification of bacterial pathogens
    4. Describe ability for breakthrough diagnostic technology to improve empiric therapy and provide faster, targeted therapy 


    Show Resources
    You May Also Like
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    DEC 09, 2020 9:00 AM PST
    C.E. CREDITS
    DEC 09, 2020 9:00 AM PST
    DATE: December 09, 2020 TIME: 09:00am PST Hematopoietic stem cells (HSCs) ensure homeostasis of blood throughout life. In this webinar, we share insights into the smart and easy isolation, c...
    AUG 18, 2020 10:00 AM PDT
    C.E. CREDITS
    AUG 18, 2020 10:00 AM PDT
    DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 14, 2018 6:00 AM PST

    Improving Sepsis Management with Same-Day Results from the Lab


    Specialty

    Cancer Research

    Molecular Diagnostics

    Laboratory Testing

    Cancer Therapeutics

    Clinical Research

    Cancer Diagnostics

    Point Of Care

    Microbiology

    Immunology

    Analytical Chemistry

    Genomics

    Brain Diseases

    Diagnostics

    Bacteria

    Next-Generation Sequencing

    Geography

    North America71%

    Asia29%

    Registration Source

    Website Visitors100%

    Job Title

    Medical Doctor/Specialist33%

    Student17%

    Clinical Laboratory Scientist17%

    Executive17%

    Facility/Department Manager17%

    Organization

    Hospital43%

    Medical Center14%

    Life Science Company14%

    Academic Institution14%

    Diagnostic Company14%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more